The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013

PART 5 U.K. Specific grounds for refusal or deferral of applications under Parts 3 and 4 which are not linked to fitness grounds

Refusal: language requirement for some NHS pharmacists U.K.

30.  An application for inclusion in a pharmaceutical list by a person not already included must be refused if the applicant is an individual (X) who qualified as a pharmacist in Switzerland or an EEA state other than the United Kingdom, unless X satisfies the NHSCB that X has the level of knowledge of English which, in the interests of X and the persons making use of the services to which the application relates, is necessary for the provision of those services in the area of the relevant HWB.

Refusal: same or adjacent premises U.K.

31.— [F1 (1) A routine or excepted application must be refused where paragraph (2) applies.]

(2) This paragraph applies where—

(a) a person on the pharmaceutical list (which may or may not be the applicant) is providing or has undertaken to provide pharmaceutical services (“the existing services”) from—

(i) the premises to which the application relates, or

(ii) adjacent premises; and

(b) the NHSCB is satisfied that it is reasonable to treat the services that the applicant proposes to provide as part of the same service as the existing services (and so the premises to which the application relates and the existing listed chemist premises should be treated as the same site).

Textual Amendments

F1 Reg. 31(1) substituted (1.4.2014) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2014 (S.I. 2014/417), regs. 1, 10

Deferrals arising out of LPS designations U.K.

32.— [F2 (1) A routine application must be refused where paragraph (2) applies to the relevant premises.]

(2) This paragraph applies where the relevant premises are premises or part of premises, or are located within an area, designated under—

(a) regulation 99; or

(b) regulation 4 of the 2006 Regulations M1 (designation of priority neighbourhoods or premises),

and that designation has neither been varied so that it no longer applies to the relevant premises nor been cancelled.

(3) For the purposes of this regulation, “the relevant premises” are—

(a) the listed chemist premises or proposed listed chemist premises in the application; or

(b) as regards an application for inclusion in a pharmaceutical list by a person not already included, if no particular premises are proposed for listing in the application, premises located at the best estimate that the NHSCB is able to make as to where the proposed listed chemist premises would be, having regard to the best estimate given by the applicant under paragraph 1(7)(a)(ii) of Schedule 2.

Textual Amendments

F2 Reg. 32(1) substituted (1.4.2014) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2014 (S.I. 2014/417), regs. 1, 11

Marginal Citations

M1 Prior to its revocation, regulation 4 was amended by S.I. 2009/599 and 2010/914.